Fate and analysis of pharmaceutical residues in the aquatic environment

被引:108
作者
Debska, J [1 ]
Kot-Wasik, A [1 ]
Namiesnik, J [1 ]
机构
[1] Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland
关键词
analysis; aquatic ecosystem; emission sources; fate; pharmaceutical residues;
D O I
10.1080/10408340490273753
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The presence of pharmaceuticals in different compartments of the environment is a new challenge not only for technologists of water and wastewater treatment but also for analytical chemists involved in development of new analytical methods. Many drugs are not completely degraded in the human body. They are often excreted after only slight transformation or in unchanged form, mainly as polar molecules (clofibric acid, primidone). It has been proved in many studies that substances of pharmaceutical origin are not eliminated in the process of water treatment; their biodegradation in the environment is also difficult (1). Detailed chemical analysis of water is necessary for the safe use of water resources. It is important to identify all pollutants present in water and, hence, to fully evaluate water quality and predict effect on humans. The continuous improvement of analytical techniques makes it possible to identify a wider spectrum of components and improve detection limits. A brief review of input by different sources, and fate and analysis of pharmaceuticals, parapharmaceuticals, and their metabolites in environment is presented.
引用
收藏
页码:51 / 67
页数:17
相关论文
共 133 条
[1]   Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry [J].
Ahrer, W ;
Scherwenk, E ;
Buchberger, W .
JOURNAL OF CHROMATOGRAPHY A, 2001, 910 (01) :69-78
[2]  
Ahrer W, 2001, AM LAB, V33, P31
[3]   Assessment of organic contaminant fate in waste water treatment plants I: Selected compounds and physicochemical properties [J].
Alcock, RE ;
Sweetman, A ;
Jones, KC .
CHEMOSPHERE, 1999, 38 (10) :2247-2262
[4]  
Alder A.C., 2001, PHARM PERSONAL CARE, VVolume 791, P56, DOI [10.1021/bk-2001-0791.ch003, DOI 10.1021/BK-2001-0791.CH003, 10.1021/bk-2001-0791, DOI 10.1021/BK-2001-0791]
[5]   Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity [J].
Andreozzi, R ;
Marotta, R ;
Pinto, G ;
Pollio, A .
WATER RESEARCH, 2002, 36 (11) :2869-2877
[6]   Natural and synthetic organic compounds in the environment - a symposium report [J].
Ariese, F ;
Ernst, WHO ;
Sijm, DTHM .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2001, 10 (03) :65-80
[7]   Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water [J].
Baronti, C ;
Curini, R ;
D'Ascenzo, G ;
Di Corcia, A ;
Gentili, A ;
Samperi, R .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2000, 34 (24) :5059-5066
[8]  
Boyd GR, 2001, ANN NY ACAD SCI, V948, P80
[9]   Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea [J].
Buser, HR ;
Muller, MD ;
Theobald, N .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1998, 32 (01) :188-192
[10]   Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater [J].
Buser, HR ;
Poiger, T ;
Muller, MD .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1999, 33 (15) :2529-2535